Cargando…
C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin
BACKGROUND: Amrubicin hydrochloride (AMR) is a key agent for lung cancer. NADPH quinone oxidoreductase 1 (NQO1) metabolizes the quinone structures contained in both amrubicin (AMR) and amrubicinol (AMR-OH). We hypothesized that NQO1 C609T polymorphism may affect AMR-related pharmacokinetics and clin...
Autores principales: | Nagata, Misato, Kimura, Tatsuo, Suzumura, Tomohiro, Kira, Yukimi, Nakai, Toshiyuki, Umekawa, Kanako, Tanaka, Hidenori, Matsuura, Kuniomi, Mitsuoka, Shigeki, Yoshimura, Naruo, Oka, Takako, Kudoh, Shinzoh, Hirata, Kazuto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576865/ https://www.ncbi.nlm.nih.gov/pubmed/23467445 http://dx.doi.org/10.4137/CMO.S10839 |
Ejemplares similares
-
Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs
por: Umekawa, Kanako, et al.
Publicado: (2013) -
Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
por: Suzumura, Tomohiro, et al.
Publicado: (2012) -
Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study
por: Oka, Takako, et al.
Publicado: (2014) -
Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
por: Kimura, Tatsuo, et al.
Publicado: (2011) -
Lack of Association between NADPH Quinone Oxidoreductase 1 (NQO1) Gene C609T Polymorphism and Lung Cancer: A Case-Control Study and a Meta-Analysis
por: Guo, Shujie, et al.
Publicado: (2012)